1. Home
  2. ROIV vs CE Comparison

ROIV vs CE Comparison

Compare ROIV & CE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ROIV
  • CE
  • Stock Information
  • Founded
  • ROIV 2014
  • CE 1918
  • Country
  • ROIV United Kingdom
  • CE United States
  • Employees
  • ROIV N/A
  • CE N/A
  • Industry
  • ROIV Biotechnology: Pharmaceutical Preparations
  • CE Major Chemicals
  • Sector
  • ROIV Health Care
  • CE Industrials
  • Exchange
  • ROIV Nasdaq
  • CE Nasdaq
  • Market Cap
  • ROIV 8.4B
  • CE 7.8B
  • IPO Year
  • ROIV N/A
  • CE 2005
  • Fundamental
  • Price
  • ROIV $10.38
  • CE $57.22
  • Analyst Decision
  • ROIV Strong Buy
  • CE Hold
  • Analyst Count
  • ROIV 6
  • CE 16
  • Target Price
  • ROIV $17.10
  • CE $71.75
  • AVG Volume (30 Days)
  • ROIV 6.9M
  • CE 4.1M
  • Earning Date
  • ROIV 02-10-2025
  • CE 05-07-2025
  • Dividend Yield
  • ROIV N/A
  • CE 3.72%
  • EPS Growth
  • ROIV N/A
  • CE N/A
  • EPS
  • ROIV N/A
  • CE N/A
  • Revenue
  • ROIV $122,585,000.00
  • CE $10,280,000,000.00
  • Revenue This Year
  • ROIV N/A
  • CE N/A
  • Revenue Next Year
  • ROIV N/A
  • CE $4.17
  • P/E Ratio
  • ROIV N/A
  • CE N/A
  • Revenue Growth
  • ROIV 140.04
  • CE N/A
  • 52 Week Low
  • ROIV $9.96
  • CE $45.94
  • 52 Week High
  • ROIV $13.06
  • CE $172.10
  • Technical
  • Relative Strength Index (RSI)
  • ROIV 42.16
  • CE 48.07
  • Support Level
  • ROIV $10.63
  • CE $55.42
  • Resistance Level
  • ROIV $11.42
  • CE $60.84
  • Average True Range (ATR)
  • ROIV 0.36
  • CE 2.15
  • MACD
  • ROIV -0.02
  • CE 0.76
  • Stochastic Oscillator
  • ROIV 7.59
  • CE 57.10

About ROIV Roivant Sciences Ltd.

Roivant Sciences Ltd is a commercial-stage biopharmaceutical company dedicated to improving the delivery of healthcare to patients. It also incubates discovery-stage companies and health technology startups complementary to its biopharmaceutical business. Its drug candidate VTAMA (tapinarof) is a treatment of plaque psoriasis in adult patients and is in its commercial stage. The other drug candidates in their different stages of development are; Batoclimab, IMVT-1402, Brepocitinib, Namilumab, and others.

About CE Celanese Corporation

Celanese is one of the world's largest producers of acetic acid and its downstream derivative chemicals, which are used in various end markets, including coatings and adhesives. The company is also one of the largest producers of specialty polymers, which are used in the automotive, electronics, medical, building, and consumer end markets. The company also makes cellulose derivatives used in cigarette filters.

Share on Social Networks: